Roundtable Discussion: Genetics Anchored Animal Models as a New Foundation for Psychosis Drug Discovery

  • Leveraging large scale human genetics to define biologically grounded entry points for schizophrenia and bipolar disorder
  • Designing next generation animal models that capture disease relevant circuits and synaptic phenotypes rather than surface behaviors alone
  • Using genetically informed models to distinguish causal mechanisms from downstream correlates in psychotic disorders
  • How genetics anchored models can enable more rational discovery of novel drug targets and translational biomarkers